CLINICAL_TRIALS
trial_result
· 2010-01-07
Clinical Trial Update: Study Evaluating Rapamune® Maintenance Regimen [Phase 3]
Summary
Phase 3 study evaluating a Rapamune maintenance regimen in renal transplant recipients completed, with results posted in 2010.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Renal Transplant | Phase 3 | Status: COMPLETED | Results posted: 2010-01-07